These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
560 related items for PubMed ID: 15057430
1. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival. Tsamandas AC, Kardamakis D, Ravazoula P, Zolota V, Salakou S, Tepetes K, Kalogeropoulou C, Tsota I, Kourelis T, Makatsoris T, Karavias D, Scopa CD, Bonikos DS, Kalofonos HP, Petsas T. Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430 [Abstract] [Full Text] [Related]
2. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival. Vagenas K, Spyropoulos C, Gavala V, Tsamandas AC. J Surg Res; 2007 May 15; 139(2):182-8. PubMed ID: 17270215 [Abstract] [Full Text] [Related]
3. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C. Oncology; 2006 May 15; 70(5):366-77. PubMed ID: 17179731 [Abstract] [Full Text] [Related]
4. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome. Tsamandas AC, Kardamakis D, Tsiamalos P, Liava A, Tzelepi V, Vassiliou V, Petsas T, Vagenas K, Zolota V, Scopa CD. Anticancer Res; 2009 Feb 15; 29(2):703-9. PubMed ID: 19331225 [Abstract] [Full Text] [Related]
7. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML. Clin Cancer Res; 1997 Jun 15; 3(6):999-1007. PubMed ID: 9815777 [Abstract] [Full Text] [Related]
8. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients. Gal R, Sadikov E, Sulkes J, Klein B, Koren R. Dis Colon Rectum; 2004 Jul 15; 47(7):1216-24. PubMed ID: 15148649 [Abstract] [Full Text] [Related]
9. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas. Xue G, Hao LQ, Ding FX, Mei Q, Huang JJ, Fu CG, Yan HL, Sun SH. J Clin Gastroenterol; 2009 Oct 15; 43(9):831-7. PubMed ID: 19461527 [Abstract] [Full Text] [Related]
10. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. Jantscheff P, Terracciano L, Lowy A, Glatz-Krieger K, Grunert F, Micheel B, Brümmer J, Laffer U, Metzger U, Herrmann R, Rochlitz C. J Clin Oncol; 2003 Oct 01; 21(19):3638-46. PubMed ID: 14512395 [Abstract] [Full Text] [Related]
11. Simultaneous detection of apoptosis and proliferation in colorectal carcinoma by multiparameter flow cytometry allows separation of high and low-turnover tumors with distinct clinical outcome. Rupa JD, de Bruïne AP, Gerbers AJ, Leers MP, Nap M, Kessels AG, Schutte B, Arends JW. Cancer; 2003 May 15; 97(10):2404-11. PubMed ID: 12733138 [Abstract] [Full Text] [Related]
12. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Cancer; 2007 Feb 15; 109(4):658-67. PubMed ID: 17211865 [Abstract] [Full Text] [Related]
15. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer. Ladner RD, Lynch FJ, Groshen S, Xiong YP, Sherrod A, Caradonna SJ, Stoehlmacher J, Lenz HJ. Cancer Res; 2000 Jul 01; 60(13):3493-503. PubMed ID: 10910061 [Abstract] [Full Text] [Related]
16. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis. Hu WG, Li JW, Feng B, Beveridge M, Yue F, Lu AG, Ma JJ, Wang ML, Guo Y, Jin XL, Zheng MH. Eur Surg Res; 2007 Jul 01; 39(4):229-38. PubMed ID: 17446709 [Abstract] [Full Text] [Related]
17. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma. Ren DN, Kim IY, Koh SB, Chang SJ, Eom M, Yi SY, Seong SH, Kim MD, Bronner MP, Cho MY. J Surg Oncol; 2009 Dec 01; 100(7):546-52. PubMed ID: 19722231 [Abstract] [Full Text] [Related]
18. Clinical prognostic factors in malignant parotid gland tumors. Lima RA, Tavares MR, Dias FL, Kligerman J, Nascimento MF, Barbosa MM, Cernea CR, Soares JR, Santos IC, Salviano S. Otolaryngol Head Neck Surg; 2005 Nov 01; 133(5):702-8. PubMed ID: 16274796 [Abstract] [Full Text] [Related]
19. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma. Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Reich R. Clin Cancer Res; 2003 Apr 01; 9(4):1412-9. PubMed ID: 12684413 [Abstract] [Full Text] [Related]
20. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance. Lin A, Weiser MR, Klimstra DS, Paty PB, Tang LH, Al-Ahmadie H, Hoo Park S, Guillem JG, Temple L, Wong WD, Gerald WL, Shia J. Hum Pathol; 2007 Jun 01; 38(6):850-6. PubMed ID: 17442371 [Abstract] [Full Text] [Related] Page: [Next] [New Search]